PMID

Data

Article Title

Organization

In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.

Astrazeneca

Troglitazone-induced intrahepatic cholestasis by an interference with the hepatobiliary export of bile acids in male and female rats. Correlation with the gender difference in troglitazone sulfate formation and the inhibition of the canalicular bile salt export pump (Bsep) by troglitazone and trogl

F. Hoffmann-La Roche

Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver.

University Hospital

Characterization of bile acid transport mediated by multidrug resistance associated protein 2 and bile salt export pump.

The University Of Tokyo

The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions.

University Of Zurich

Inhibition of transport across the hepatocyte canalicular membrane by the antibiotic fusidate.

Deutsches Krebsforschungszentrum

Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.

Astrazeneca

Bile salt export pump (BSEP/ABCB11) can transport a nonbile acid substrate, pravastatin.

University Of Tokyo